Impact/Purpose:

A substantial body of scientific literature has associated airborne particulate matter exposures, PM₁₀ and PM_2.5, with health outcomes, most significantly with cardiovascular and respiratory disease mortality and morbidity in adults, and with asthma exacerbations in children. This project utilizes existing data to develop and evaluate a set of outcome-based indicators for monitoring the impacts of several local and national particulate matter emission reduction strategies in the Minneapolis-St. Paul area and Olmsted County on population distributions of ambient PM exposures, and on population health.

Description:

Quantifiable indicators will measure the progress of local and national PM reduction strategies in lowering population exposure to PM and positively impacting public health. These environmental health outcome indicators will ultimately serve to inform and evaluate environmental policies and public health interventions with a goal of protecting vulnerable populations from ambient air pollutants.

URLs/Downloads:

2008 Progress Report

Record Details:

Record Type:PROJECT( ABSTRACT )

Start Date:01/01/2007

Completion Date:01/01/2010

Record ID: 205718

Show Additional Record Data

Related Organizations:

Role :OWNER

Organization Name :MINNESOTA DEPARTMENT OF HEALTH

State :MN



Role :OWNER

Organization Name :OLMSTED MEDICAL CENTER

Mailing Address :210 Ninth Street SE

Citation :Rochester

State :MN

Zip Code :55904



Role :OWNER

Organization Name :MINNESOTA POLLUTION CONTROL AGENCY

Mailing Address :520 Lafayette Road

Citation :St. Paul

State :MN

Zip Code :55155

Project Information:

Approach :

Using 10 years of available data (2000-2009) indicators of population exposure to ambient PM_2.5, PM₁₀, and PM speciation will be developed from ambient monitoring data and spatial modeling techniques. Indicators of population health (cardiovascular and respiratory disease events and rates) will be developed from statewide mortality, hospitalization, and emergency services data. Indicators of primary care for asthma exacerbations in children (clinic visits and oral steroid Rxs) will be developed from Rochester Epidemiology Project data. Relative risks will be estimated and compared using case-crossover and time series methods for associating daily PM exposures with acute health outcome indicators. Following the implementation of several PM reduction initiatives during the study period, changes in the population attributable fraction (AFp) indicator from baseline will be reported for each health outcome and human health impacts in the population and in sensitive subgroups will be assessed.

Cost :$488,650.00

Research Component :Health Effects

Project IDs:

ID Code :R833627

Project type :EPA Grant